AMERICAN CENTURY COMPANIES INC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$937,207
+73.6%
216,946
+164.8%
0.00%
Q2 2023$539,879
+313.3%
81,924
+320.9%
0.00%
Q1 2023$130,617
-61.3%
19,466
-57.4%
0.00%
Q4 2022$337,819
-11.6%
45,713
+18.1%
0.00%
Q3 2022$382,000
-38.9%
38,713
-29.9%
0.00%
Q1 2022$625,000
-27.7%
55,245
+0.3%
0.00%
-100.0%
Q4 2021$865,000
-8.4%
55,1040.0%0.00%0.0%
Q3 2021$944,000
-19.2%
55,104
+1.4%
0.00%0.0%
Q2 2021$1,169,000
+43.3%
54,3430.0%0.00%0.0%
Q1 2021$816,000
+17.6%
54,343
+3.0%
0.00%0.0%
Q4 2020$694,000
-13.7%
52,778
-36.6%
0.00%0.0%
Q3 2020$804,000
-2.3%
83,252
+15.7%
0.00%0.0%
Q2 2020$823,000
-19.2%
71,951
-26.8%
0.00%0.0%
Q1 2020$1,018,000
-19.6%
98,262
+27.4%
0.00%0.0%
Q4 2019$1,266,000
-54.7%
77,126
-63.4%
0.00%
-66.7%
Q3 2019$2,796,000
+34.2%
210,540
+86.0%
0.00%
+50.0%
Q1 2019$2,083,000
-28.9%
113,208
+1.0%
0.00%
-33.3%
Q4 2018$2,929,000
-17.9%
112,105
-27.9%
0.00%0.0%
Q3 2018$3,567,000
+211.5%
155,431
+158.6%
0.00%
+200.0%
Q2 2018$1,145,000
-25.8%
60,106
-35.2%
0.00%
-50.0%
Q3 2016$1,543,00092,7000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders